gimli
LUPIN stock analysis context
LUPIN Stock Context for AI Screening
LUPIN LIMITED is a mid-cap stock in Healthcare. This page summarizes key screening signals for LUPIN, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about LUPINPrice
₹2,281.80
1M return
-1.13%
3M return
+2.81%
Market cap
₹104,327.52 cr
PE
22.55
ROE
+29.22%
RSI
47.33
Turnover
₹279.57 cr
Why it can matter in screens
- Momentum: LUPIN is above 200DMA; RSI is 47.33.
- Returns: 1M -1.13%, 3M +2.81%, 6M +12.44%.
- Liquidity: latest turnover is ₹279.57 cr.
- Valuation: PE 22.55, PB 4.63, ROE +29.22%, ROCE +30.86%.
- Growth: 3Y sales CAGR +11.07%, 3Y profit CAGR n/a.
Try these prompts
- Analyze LUPIN with valuation, momentum and industry peers
- Compare LUPIN with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare LUPIN with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.